AbFero Pharmaceuticals Announces Initiation Of Phase 1 Study For Lead Iron Chelator; Study to Examine Safety of SP-420 in MDS and MF

Press/Media: Press / Media

PeriodFeb 23 2021

Media coverage

1

Media coverage

  • TitleAbFero Pharmaceuticals Announces Initiation Of Phase 1 Study For Lead Iron Chelator; Study to Examine Safety of SP-420 in MDS and MF
    Media name/outletPR Newswire
    CountryUnited States
    Date2/23/21
    PersonsRuben Mesa